Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
AASLD 2021Liver Cancer Risk Lingers Even After HCV EradicationRisk for hepatocellular carcinoma (HCC) is lower for patients who have sustained viral responses after drug therapy for hepatitis C, but this treatment does not cure fibrosis, a common cause of HCC.
Aspirin and Statins in Chronic Hepatitis B: It's ComplicatedStatins play a bigger part than aspirin in reducing risk for hepatocellular carcinoma in patients with hepatitis B, new research
shows, and cirrhosis seems to cancel any beneficial effect of aspirin.
Medscape Medical News, Nov 19, 2020
Liquid Biopsy Captures Key NASH Pathology HallmarksLarge-scale proteomics could serve as an alternative to invasive liver biopsy for the noninvasive screening and monitoring
of patients with nonalcoholic steatohepatitis (NASH).
